| Literature DB >> 28165422 |
Qin Liu1,2, Mengjuan Zhu3, Xueran Geng4, Hexiang Wang5, Tzi Bun Ng6.
Abstract
The preliminary structure, in vitro antioxidant and in vivo hepatoprotective activities of water-soluble polysaccharides (ORWP) and alkali-soluble polysaccharides (ORAP), prepared from the mushroom Oudemansiella radicata, were investigated. Both ORWP and ORAP were heteropolysaccharides with mannose, glucose and galactose being the main monosaccharide components. Regarding the antioxidant activities, ORWP and ORAP showed effective 1,1-diphenyl-2-picrylhydrazyl (DPPH) radical scavenging activity, hydrogen peroxide scavenging activity and lipid peroxidation inhibitory effects, as well as moderate reducing power and Fe2+ chelating activity. For the hepatoprotective activity, administration of ORWP and ORAP prevented the increase in serum alanine aminotransferase and aspartate aminotransferase activities in a carbon tetrachloride-induced acute liver damage model, suppressed hepatic malondialdehyde formation and stimulated the activities of hepatic superoxide dismutase and glutathione peroxidase. Thus, we speculate that ORWP and ORAP may protect the liver from CCl₄-induced hepatic damage via antioxidant mechanisms.Entities:
Keywords: Oudemansiella radicata; antioxidant; hepatoprotective; polysaccharides
Mesh:
Substances:
Year: 2017 PMID: 28165422 PMCID: PMC6155583 DOI: 10.3390/molecules22020234
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
General compositions, constituent monosaccharides and molecular weights of ORWP and ORAP.
| Property/Component | ORWP | ORAP |
|---|---|---|
| Molecular weight (Da) | 1.73 × 105 | 1.15 × 104 |
| Carbohydrate (wt %) | 95.3 | 97.4 |
| Protein (wt %) | ND | ND |
| Components of monosaccharide (mol %) | ||
| Ribose | 0.15 | 0.16 |
| Rhamnose | 0.32 | 0.51 |
| Arabinose | 1.02 | 1.02 |
| Xylose | 2.45 | 3.31 |
| Mannose | 15.74 | 18.41 |
| Glucose | 65.85 | 72.35 |
| Galactose | 14.47 | 4.24 |
Figure 1FT-IR spectrum of (a) ORWP and (b) ORAP.
Figure 2Antioxidant activity of ORWP and ORAP. (a) scavenging of DPPH radicals; (b) inhibitory effect on lipid peroxidation; (c) hydrogen peroxide scavenging activity; (d) reducing power; and (e) Fe2+ ion chelating activity. The values are representative of three separate experiments.
Effects of ORWP and ORAP on body weight, liver weight and hepatosomatic index (HI) in CCl4-treated mice.
| Treatment | Dose (ORWP/ORAP) | Body wt. (g) | Liver wt. (g) | HI (%) |
|---|---|---|---|---|
| Normal | 29.13 ± 3.22 | 1.23 ± 0.20 | 42.24 ± 2.87 | |
| CCl4 alone | 29.07 ± 1.50 | 1.54 ± 0.09 ## | 53.25 ± 3.48 ### | |
| CCl4 + bifendate | 200 mg/kg | 29.86 ± 1.10 | 1.39 ± 0.12 ** | 46.66 ± 4.12 *** |
| CCl4 + ORWP | 100 mg/kg | 29.29 ± 2.71 | 1.46 ± 0.16 | 49.87 ± 3.36 * |
| CCl4 + ORWP | 200 mg/kg | 29.41 ± 1.61 | 1.43 ± 0.08 * | 48.50 ± 1.92 ** |
| CCl4 + ORAP | 100 mg/kg | 29.23 ± 1.21 | 1.42 ± 0.16 * | 48.44 ± 4.53 ** |
| CCl4 + ORAP | 200 mg/kg | 29.18 ± 2.22 | 1.39 ± 0.17 ** | 47.46 ± 2.98 *** |
Mice were randomized into seven groups: control group (normal control), CCl4-intoxicated (CCl4 only group), bifendate pretreatment at 200 mg/kg plus CCl4-intoxication (CCl4 + bifendate group), ORWP pretreatment at 100 mg/kg plus CCl4-intoxication (CCl4 + ORWP group), ORWP pretreatment at 200 mg/kg plus CCl4-intoxication (CCl4 + ORWP group), pretreatment with ORAP at 100 mg/kg plus CCl4-intoxication (CCl4 + ORAP group), ORAP pretreatment at 200 mg/kg plus CCl4-intoxication (CCl4 + ORAP group). CCl4-induced hepatotoxic mice were given a CCl4/peanut oil mixture by intragastric (i.g.) gavage (1%, 5 mL/kg), while the normal control group received peanut oil alone. The values represent means ± SD of eight mice/group. ### p < 0.001, ## p < 0.01 compared with normal control; *** p < 0.001, ** p < 0.01 and * p < 0.05 compared with the CCl4-intoxication group.
Figure 3Effects of ORWP and ORAP on the activity of serum AST (a) and ALT (b) in CCl4-treated mice. The values represent means ± SD of eight mice/group. ### p < 0.001 versus normal control, *** p < 0.001, ** p < 0.01 and * p < 0.05 versus CCl4-intoxicated group.
Figure 4Effects of ORWP and ORAP on hepatic (a) MDA content; (b) GSH-Px activity and (c) SOD activity in CCl4-treated mice. The values represent means ± SD of eight mice/group. ### p < 0.001 compared with control, *** p < 0.001, ** p < 0.01 and * p < 0.05 versus CCl4-intoxicated group.
Figure 5Effects of ORWP and ORAP on liver as disclosed by morphological analysis (×400 H&E staining). (a) normal control group; (b) CCl4-intoxicated group; (c) bifendate positive control group (200 mg/kg) + CCl4; (d) ORWP (100 mg/kg) + CCl4; (e) ORWP (200 mg/kg) + CCl4; (f) ORAP (100 mg/kg) + CCl4; (g) ORAP (200 mg/kg) + CCl4. Black arrows indicate necrotic zones; red arrows indicate lipid droplet accumulation.